PAVmed (PAVM) Treasury Shares (2017 - 2025)

PAVmed's Treasury Shares history runs 1 years deep, the most recent figure standing at $408000.0 for Q4 2022.

• On a quarterly basis, Treasury Shares rose 526.57% year-over-year to $67739.0 in Q4 2025; TTM through Dec 2025 was $67739.0, a 526.57% increase from a year earlier, with the FY2025 full-year figure at $67739.0, down 97.8% from the prior year.
• Treasury Shares eased to $67739.0 in Q4 2025 per PAVM's latest filing, from $3.1 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.9 million in Q2 2024 and bottomed at $10811.0 in Q4 2024.
• The 5-year median for Treasury Shares is $1.9 million (2023), against an average of $1.6 million.
• Across the five-year window, Treasury Shares surged 3496.17% in 2023 and plunged 99.54% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $1.9 million in 2021, then tumbled by 96.65% to $64998.0 in 2022, then jumped by 3496.17% to $2.3 million in 2023, then tumbled by 99.54% to $10811.0 in 2024, then soared by 526.57% to $67739.0 in 2025.
• Per Business Quant, the three latest PAVM Treasury Shares figures stand at $408000.0 (Q4 2022), $408000.0 (Q3 2022), and $548000.0 (Q2 2022).